Free Trial

Genpact Limited $G Position Reduced by Canada Pension Plan Investment Board

Genpact logo with Computer and Technology background

Key Points

  • Canada Pension Plan Investment Board sold 22,900 shares of Genpact Limited, reducing its stake by 22.2%, and now holds 80,200 shares valued at approximately $4,040,000.
  • Several institutional investors have increased their holdings in Genpact, with 96.03% of the stock currently owned by institutional investors.
  • Genpact recently declared a quarterly dividend of $0.17 per share, with an annualized yield of 1.5%, set to be paid on September 25th.
  • MarketBeat previews the top five stocks to own by November 1st.

Canada Pension Plan Investment Board reduced its holdings in shares of Genpact Limited (NYSE:G - Free Report) by 22.2% in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 80,200 shares of the business services provider's stock after selling 22,900 shares during the quarter. Canada Pension Plan Investment Board's holdings in Genpact were worth $4,040,000 at the end of the most recent quarter.

Several other institutional investors also recently bought and sold shares of the business. State of Wyoming grew its stake in Genpact by 78.5% during the first quarter. State of Wyoming now owns 11,669 shares of the business services provider's stock worth $588,000 after buying an additional 5,133 shares during the period. Trexquant Investment LP grew its stake in Genpact by 1.1% during the first quarter. Trexquant Investment LP now owns 241,781 shares of the business services provider's stock worth $12,181,000 after buying an additional 2,654 shares during the period. Transamerica Financial Advisors LLC purchased a new stake in Genpact during the first quarter worth approximately $149,000. Ieq Capital LLC grew its stake in Genpact by 4.8% during the first quarter. Ieq Capital LLC now owns 11,457 shares of the business services provider's stock worth $577,000 after buying an additional 525 shares during the period. Finally, SVB Wealth LLC purchased a new stake in Genpact during the first quarter worth approximately $41,000. 96.03% of the stock is currently owned by hedge funds and other institutional investors.

Genpact Stock Down 0.4%

Shares of G stock traded down $0.20 on Tuesday, hitting $44.08. The stock had a trading volume of 189,215 shares, compared to its average volume of 1,621,369. The firm has a market capitalization of $7.68 billion, a price-to-earnings ratio of 14.68, a P/E/G ratio of 1.54 and a beta of 0.92. The stock's 50 day moving average is $44.63 and its 200-day moving average is $46.09. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.53 and a current ratio of 1.53. Genpact Limited has a 52-week low of $37.82 and a 52-week high of $56.76.

Genpact (NYSE:G - Get Free Report) last announced its earnings results on Thursday, August 7th. The business services provider reported $0.88 earnings per share for the quarter, beating the consensus estimate of $0.85 by $0.03. Genpact had a net margin of 10.92% and a return on equity of 22.15%. The business had revenue of $1.25 billion during the quarter, compared to the consensus estimate of $1.23 billion. During the same period in the prior year, the firm earned $0.79 earnings per share. The business's quarterly revenue was up 6.6% compared to the same quarter last year. Genpact has set its FY 2025 guidance at 3.510-3.580 EPS. Q3 2025 guidance at 0.890-0.900 EPS. As a group, research analysts expect that Genpact Limited will post 3.21 earnings per share for the current year.

Genpact Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, September 25th. Shareholders of record on Thursday, September 11th will be paid a dividend of $0.17 per share. This represents a $0.68 dividend on an annualized basis and a yield of 1.5%. The ex-dividend date is Thursday, September 11th. Genpact's dividend payout ratio is 22.59%.

Wall Street Analysts Forecast Growth

Several equities research analysts have issued reports on G shares. JPMorgan Chase & Co. decreased their price objective on shares of Genpact from $55.00 to $50.00 and set a "neutral" rating for the company in a research note on Wednesday, August 20th. Mizuho boosted their price objective on shares of Genpact from $48.00 to $51.00 and gave the stock a "neutral" rating in a research note on Tuesday, July 1st. Wall Street Zen downgraded shares of Genpact from a "buy" rating to a "hold" rating in a research note on Friday. Needham & Company LLC upped their target price on shares of Genpact from $50.00 to $53.00 and gave the company a "buy" rating in a research note on Friday, August 8th. Finally, Deutsche Bank Aktiengesellschaft started coverage on shares of Genpact in a research note on Thursday, July 17th. They issued a "hold" rating and a $47.00 target price for the company. Three research analysts have rated the stock with a Buy rating and four have given a Hold rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of "Hold" and a consensus target price of $52.29.

Get Our Latest Report on G

About Genpact

(Free Report)

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.

Further Reading

Institutional Ownership by Quarter for Genpact (NYSE:G)

Should You Invest $1,000 in Genpact Right Now?

Before you consider Genpact, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.

While Genpact currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Related Videos

Markets Are Sliding: Where to Find Opportunity
Don’t Miss These Top 3 Defense Stocks Set To Gain

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines